Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Hepatitis C

Free Subscription Articles published in J Viral Hepat Retrieve available abstracts of 217 articles: HTML format Text format

Single Articles

March 2010
1. CHEN TM , Huang PT, Wen CF, Tung JN, et al
   Reappraisal of the importance of mutations in the NS5A-PKR-binding domain of hepatitis C-1b virus in the era of optimally individualized therapy.
   J Viral Hepat. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   February 2010
2. RYAN MC , Desmond PV, Slavin JL, Congiu M, et al
   Expression of genes involved in lipogenesis is not increased in patients with HCV genotype 3 in human liver.
   J Viral Hepat. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
3. WESTIN J , Hellstrand K, Dhillon AP, Lagging M, et al
   Are FoxP3(+) cells involved in hyporesponsiveness to interferon/ribavirin therapy in chronic hepatitis C?
   J Viral Hepat. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
4. KALLMAN JB , Tran S, Arsalla A, Haddad D, et al
   Vietnamese community screening for hepatitis B virus and hepatitis C virus.
   J Viral Hepat. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
5. GREBELY J , Raffa JD, Lai C, Kerr T, et al
   Impact of hepatitis C virus infection on all-cause and liver-related mortality in a large community-based cohort of inner city residents.
   J Viral Hepat. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
6. FU Y , Wang Y, Xia W, Pybus OG, et al
   New trends of HCV infection in China revealed by genetic analysis of viral sequences determined from first-time volunteer blood donors.
   J Viral Hepat. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
7. PATTULLO V , Ravindran NC, Mazzulli T, Wong DK, et al
   Pegylated interferon plus optimized weight-based ribavirin dosing negate the influence of weight and body mass index on early viral kinetics and sustained virological response in chronic hepatitis C.
   J Viral Hepat. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
8. PARKES J , Guha IN, Roderick P, Harris S, et al
   Enhanced Liver Fibrosis (ELF) test accurately identifies liver fibrosis in patients with chronic hepatitis C.
   J Viral Hepat. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
9. ROSENBERG P , Hagen K
   Serum B12 levels predict response to treatment with interferon and ribavirin in patients with chronic HCV infection.
   J Viral Hepat. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
10. WITTHOEFT T , Hueppe D, John C, Goelz J, et al
    Efficacy and tolerability of peginterferon alfa-2a or alfa-2b plus ribavirin in the daily routine treatment of patients with chronic hepatitis C in Germany: The PRACTICE Study.
    J Viral Hepat. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
11. DUBERG AS , Pettersson H, Aleman S, Blaxhult A, et al
    The burden of hepatitis C in Sweden: a national study of inpatient care.
    J Viral Hepat. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2010
12. MAIDA I , Martin-Carbonero L, Sotgiu G, Vispo E, et al
    Differences in liver fibrosis and response to pegylated interferon plus ribavirin in HIV/HCV-coinfected patients with normal vs elevated liver enzymes.
    J Viral Hepat. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
13. WILLIAMS MJ , Lang-Lenton M
    Progression of initially mild hepatic fibrosis in patients with chronic hepatitis C infection.
    J Viral Hepat. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
14. TRELOAR C , Newland J, Rance J, Hopwood M, et al
    Uptake and delivery of hepatitis C treatment in opiate substitution treatment: perceptions of clients and health professionals.
    J Viral Hepat. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
15. SGIER C , Mullhaupt B, Gerlach T, Moradpour D, et al
    Effect of antiviral therapy on circulating cytokeratin-18 fragments in patients with chronic hepatitis C.
    J Viral Hepat. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
16. GODOY MM , Lopes EP, Silva RO, Hallwass F, et al
    Hepatitis C virus infection diagnosis using metabonomics.
    J Viral Hepat. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
17. MAWATARI H , Yoneda M, Fujita K, Nozaki Y, et al
    Association between phospholipids and free cholesterol in high-density lipoprotein and the response to hepatitis C treatment in Japanese with genotype 1b.
    J Viral Hepat. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    December 2009
18. GREBELY J , Matthews GV, Petoumenos K, Dore GJ, et al
    Spontaneous clearance and the beneficial impact of treatment on clearance during recent hepatitis C virus infection.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles   
    
    
    
19. EKSIOGLU EA , Bess JR, Zhu H, Xu Y, et al
    Hepatitis C virus modulates human monocyte-derived dendritic cells.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
20. SCHINAZI RF , Bassit L, Gavegnano C
    HCV drug discovery aimed at viral eradication.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
21. LIM AK , Patel N, Eckersley RJ, Cobbold JF, et al
    Hepatic vein transit times of a microbubble agent in assessing response to antiviral treatment in patients with chronic hepatitis C.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
22. SHAKER O , Ahmed A, Doss W, Abdel-Hamid M, et al
    MxA expression as marker for assessing the therapeutic response in HCV genotype 4 Egyptian patients.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
23. TSOCHATZIS E , Papatheodoridis GV, Koliaraki V, Hadziyannis E, et al
    Serum hepcidin levels are related to the severity of liver histological lesions in chronic hepatitis C.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
24. WINTERMEYER P , Gehring S, Eken A, Wands JR, et al
    Generation of cellular immune responses to HCV NS5 protein through in vivo activation of dendritic cells.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
25. BIRERDINC A , Afendy A, Stepanova M, Younossi I, et al
    Functional pathway analysis of genes associated with response to treatment for chronic hepatitis C.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
26. ANTONELLI A , Ferri C, Ferrari SM, Colaci M, et al
    High levels of circulating N-terminal pro-brain natriuretic peptide in patients with hepatitis C.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
27. WANG T , Campbell RV, Yi MK, Lemon SM, et al
    Role of Hepatitis C virus core protein in viral-induced mitochondrial dysfunction.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
28. HOLLINGER FB , Sood G
    Occult hepatitis B virus infection: a covert operation.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2009
29. MICHEL L , Villes V, Dabis F, Spire B, et al
    Role of treatment for depressive symptoms in relieving the impact of fatigue in HIV-HCV co-infected patients: ANRS Co13 Hepavih, France, 2006-2008.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
30. KUKLA M , Zwirska-Korczala K, Gabriel A, Waluga M, et al
    Chemerin, vaspin and insulin resistance in chronic hepatitis C.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
31. NGUYEN NH , Vutien P, Garcia RT, Trinh H, et al
    Response to pegylated interferon and ribavirin in Asian American patients with Chronic hepatitis C genotypes 1 vs 2/3 vs 6.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
32. TAIT JM , McIntyre PG, McLeod S, Nathwani D, et al
    The impact of a managed care network on attendance, follow-up and treatment at a hepatitis C specialist centre.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
33. PINEDA JA , Gonzalez J, Ortega E, Tural C, et al
    Prevalence and factors associated with significant liver fibrosis assessed by transient elastometry in HIV/hepatitis C virus-coinfected patients.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
34. JANJUA NZ , Hamza HB, Islam M, Tirmizi SF, et al
    Health care risk factors among women and personal behaviours among men explain the high prevalence of hepatitis C virus infection in Karachi, Pakistan.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
35. ANANTHAKRISHNAN AN , McGinley EL, Fangman J, Saeian K, et al
    Hepatitis C/HIV co-infection is associated with higher mortality in hospitalized patients with Hepatitis C or HIV.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
36. CROSS TJ , Calvaruso V, Foxton MR, Manousou P, et al
    A simple, noninvasive test for the diagnosis of liver fibrosis in patients with hepatitis C recurrence after liver transplantation.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
37. DIETERICH DT , Rizzetto M, Manns MP
    Management of chronic hepatitis C patients who have relapsed or not responded to pegylated interferon alfa plus ribavirin.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
38. PUTKA B , Mullen K, Birdi S, Merheb M, et al
    The disposition of hepatitis C antibody-positive patients in an urban hospital.
    J Viral Hepat. 2009;16:814-21.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2009
39. CROSS TJ , Calvaruso V, Maimone S, Carey I, et al
    Prospective comparison of Fibroscan, King's score and liver biopsy for the assessment of cirrhosis in chronic hepatitis C infection.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
40. BORTOLETTO G , Scribano L, Realdon S, Marcolongo M, et al
    Hyperinsulinaemia reduces the 24-h virological response to PEG-interferon therapy in patients with chronic hepatitis C and insulin resistance.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
41. KUKLA M , Zwirska-Korczala K, Gabriel A, Waluga M, et al
    Visfatin serum levels in chronic hepatitis C patients.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
42. IKEZAWA K , Naito M, Yumiba T, Iwahashi K, et al
    Splenectomy and antiviral treatment for thrombocytopenic patients with chronic hepatitis C virus infection.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
43. TURNER J , Bansi L, Gilson R, Gazzard B, et al
    The prevalence of hepatitis C virus (HCV) infection in HIV-positive individuals in the UK - trends in HCV testing and the impact of HCV on HIV treatment outcomes.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
44. GIANNINI EG , Basso M, Bazzica M, Contini P, et al
    Successful antiviral therapy determines a significant decrease in squamous cell carcinoma antigen-associated (SCCA) variants' serum levels in anti-HCV positive cirrhotic patients*
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
45. CASH WJ , Patterson K, Callender ME, McDougall NI, et al
    Adjuvant therapy used in conjunction with combination therapy for chronic hepatitis C improves sustained virus response rates in genotype 1 patients.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
46. UEDA Y , Takada Y, Marusawa H, Haga H, et al
    Clinical features of biochemical cholestasis in patients with recurrent hepatitis C after living-donor liver transplantation.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
47. COBBOLD JF , Crossey MM, Colman P, Goldin RD, et al
    Optimal combinations of ultrasound-based and serum markers of disease severity in patients with chronic hepatitis C.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
48. TAKAKI A , Tatsukawa M, Iwasaki Y, Koike K, et al
    Hepatitis C virus NS4 protein impairs the Th1 polarization of immature dendritic cells.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2009
49. LUKASIEWICZ E , Gorfine M, Freedman LS, Pawlotsky JM, et al
    Prediction of nonSVR to therapy with pegylated interferon-alpha2a and ribavirin in chronic hepatitis C genotype 1 patients after 4, 8 and 12 weeks of treatment.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
50. REIBERGER T , Ferlitsch A, Sieghart W, Kreil A, et al
    HIV-HCV co-infected patients with low CD4+ cell nadirs are at risk for faster fibrosis progression and portal hypertension.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
51. WINSTON A , Garvey L, Scotney E, Yerrakalva D, et al
    Does acute hepatitis C infection affect the central nervous system in HIV-1 infected individuals?
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
52. SIR JU , Kim TY
    Autoantibodies are commonly detected by the AIT test in patients with chronic hepatitis C virus infection.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles   
    
    
    
53. CALVARUSO V , Camma C, Di Marco V, Maimone S, et al
    Fibrosis staging in chronic hepatitis C: analysis of discordance between transient elastography and liver biopsy.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
54. MORISCO F , Stroffolini T, Medda E, Amoruso DC, et al
    Retrospective, observational, multicentre study on an Italian population affected by chronic hepatitis C who failed to clear HCV-RNA after the combined therapy (PEG-IFN and ribavirin): NADIR study.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
55. DELAROCQUE-ASTAGNEAU E , Meffre C, Dubois F, Pioche C, et al
    The impact of the prevention programme of hepatitis C over more than a decade: the French experience.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
56. MIHM U , Hofmann WP, Welsch C, Polta A, et al
    Effect of ribavirin on the frequency of RNase L cleavage sites within the hepatitis C viral genome.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
57. BADER T
    Does fluvastatin favour HCV replication in vivo? A pilot study on HIV-HCV co-infected patients.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles   
    
    
    
58. MILAZZO L , Antinori S
    In vivo effects of fluvastatin on HCV replication in HIV-1 coinfected subjects.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles   
    
    
    
59. LOWRY D , Coughlan B, McCarthy O, Crowe J, et al
    Investigating health-related quality of life, mood and neuropsychological test performance in a homogeneous cohort of Irish female hepatitis C patients.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
60. GRAMENZI A , Conti F, Felline F, Cursaro C, et al
    Hepatitis C Virus-related chronic liver disease in elderly patients: an Italian cross-sectional study.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
61. SCHIAVON LL , Carvalho-Filho RJ, Narciso-Schiavon JL, Pinheiro SR, et al
    Prediction of significant liver fibrosis in kidney transplant patients with chronic hepatitis C virus infection: the TX-3 index.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
62. TAN SS , Abu Hassan MR, Abdullah A, Ooi BP, et al
    Safety and efficacy of an escalating dose regimen of pegylated interferon alpha-2b in the treatment of haemodialysis patients with chronic hepatitis C.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
63. SANCHEZ-CONDE M , Montes-Ramirez ML, Miralles P, Castro Alvarez JM, et al
    Comparison of transient elastography and liver biopsy for the assessment of liver fibrosis in HIV/hepatitis C virus-coinfected patients and correlation with noninvasive serum markers.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
64. MIYAKE Y , Takaki A, Iwasaki Y, Yamamoto K, et al
    Meta-analysis: interferon-alpha prevents the recurrence after curative treatment of hepatitis C virus-related hepatocellular carcinoma.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
65. NEGRO F , Clement S
    Impact of obesity, steatosis and insulin resistance on progression and response to therapy of hepatitis C.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2009
66. IMAI Y , Tamura S, Tanaka H, Hiramatsu N, et al
    Reduced risk of hepatocellular carcinoma after interferon therapy in aged patients with chronic hepatitis C is limited to sustained virological responders.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
67. WATANABE H , Wells F, Major ME
    Clearance of hepatitis C in chimpanzees is associated with intrahepatic T-cell perforin expression during the late acute phase.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
68. RASHKIN S , Rouster S, Goodman ZD, Sherman KE, et al
    T-helper cells and liver fibrosis in hepatitis C virus-monoinfected patients.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
69. OMLAND LH , Jepsen P, Weis N, Christensen PB, et al
    Mortality in HIV-infected injection drug users with active vs cleared hepatitis C virus-infection: a population-based cohort study.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
70. MAWATARI H , Yoneda M, Fujita K, Nozaki Y, et al
    Association between lipoprotein subfraction profile and the response to hepatitis C treatment in Japanese patients with genotype 1b.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
71. INOUE Y , Hiramatsu N, Oze T, Yakushijin T, et al
    Factors affecting efficacy in patients with genotype 2 chronic hepatitis C treated by pegylated interferon alpha-2b and ribavirin: reducing drug doses has no impact on rapid and sustained virological responses.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
72. BEKKER V , Chanock SJ, Yeager M, Hutchinson AA, et al
    Genetic variation in CLDN1 and susceptibility to hepatitis C virus infection.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
73. COREY KE , Mendez-Navarro J, Gorospe EC, Zheng H, et al
    Early treatment improves outcomes in acute hepatitis C virus infection: a meta-analysis.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
74. FOSTER GR
    Quality of life considerations for patients with chronic hepatitis C.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
75. YUKI N , Matsumoto S, Kato M, Yamaguchi T, et al
    Hepatic Toll-like receptor 3 expression in chronic hepatitis C genotype 1 correlates with treatment response to peginterferon plus ribavirin.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
76. RODRIGUEZ-TORRES M , Sulkowski MS, Chung RT, Hamzeh FM, et al
    Factors associated with rapid and early virologic response to peginterferon alfa-2a/ribavirin treatment in HCV genotype 1 patients representative of the general chronic hepatitis C population.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
77. BOYD A , Lacombe K, Miailhes P, Gozlan J, et al
    Longitudinal evaluation of viral interactions in treated HIV-hepatitis B co-infected patients with additional hepatitis C and D virus.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
78. JENKE AC , Moser S, Orth V, Zilbauer M, et al
    Mutation frequency of NS5A in patients vertically infected with HCV genotype 1 predicts sustained virological response to peginterferon alfa-2b and ribavirin combination therapy.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2009
79. SROCZYNSKI G , Esteban E, Conrads-Frank A, Schwarzer R, et al
    Long-term effectiveness and cost-effectiveness of antiviral treatment in hepatitis C.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
80. LAWSON A
    Hepatitis C virus-infected patients with a persistently normal alanine aminotransferase: do they exist and is this really a group with mild disease?
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
81. YUAN HJ , Jain M, Snow KK, Gale Jr M, et al
    Evolution of hepatitis C virus NS5A region in breakthrough patients during pegylated interferon and ribavirin therapy*
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
82. ALAVIAN SM , Tabatabaei SV
    Treatment of chronic hepatitis C in polytransfused thalassaemic patients: a meta-analysis.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    June 2009
83. HENDERSON WA , Shankar R, Gill JM, Kim KH, et al
    Hepatitis C progressing to hepatocellular carcinoma: the HCV dialysis patient in dilemma.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
84. OHKI T , Tateishi R, Goto E, Sato T, et al
    Influence of anti-HBc seropositivity on the risk of hepatocellular carcinoma in HCV-infected patients after adjusting for confounding factors.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
85. HEIDRICH B , Deterding K, Tillmann HL, Raupach R, et al
    Virological and clinical characteristics of delta hepatitis in Central Europe.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
86. HIRAMATSU N , Oze T, Yakushijin T, Inoue Y, et al
    Ribavirin dose reduction raises relapse rate dose-dependently in genotype 1 patients with hepatitis C responding to pegylated interferon alpha-2b plus ribavirin.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
87. OZE T , Hiramatsu N, Yakushijin T, Kurokawa M, et al
    Pegylated interferon alpha-2b (Peg-IFN alpha-2b) affects early virologic response dose-dependently in patients with chronic hepatitis C genotype 1 during treatment with Peg-IFN alpha-2b plus ribavirin.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
88. THOMPSON AJ , McHutchison JG
    Antiviral resistance and specifically targeted therapy for HCV (STAT-C).
    J Viral Hepat. 2009;16:377-87.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2009
89. ACALOVSCHI M , Buzas C, Radu C, Grigorescu M, et al
    Hepatitis C virus infection is a risk factor for gallstone disease: a prospective hospital-based study of patients with chronic viral C hepatitis.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
90. ITOSE I , Kanto T, Kakita N, Takebe S, et al
    Enhanced ability of regulatory T cells in chronic hepatitis C patients with persistently normal alanine aminotransferase levels than those with active hepatitis.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
91. WIEGAND J , Luz B, Mengelkamp AK, Moog R, et al
    Autologous blood donor screening indicated a lower prevalence of viral hepatitis in East vs West Germany: epidemiological benefit from established health resources.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
92. ARENDS JE , Stuart JC, Baak LC, van der Ende ME, et al
    Plasma HCV-RNA decline in the first 48 h identifies hepatitis C virus mono-infected but not HCV/HIV-coinfected patients with an undetectable HCV viral load at week 4 of peginterferon-alfa-2a/ribavirin therapy.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
93. DELTENRE P , Canva V, Nady ME, Francois C, et al
    A 2-log drop in viral load at 1 month is the best predictor of sustained response in HCV patients with normal ALT: a kinetic prospective study.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
94. CHOU R , Chan BK
    Error in calculation of indirect analyses.
    J Viral Hepat. 2009;16:376.
    PubMed     Text format     Related articles   
    
    
    April 2009
95. MARTIN-CARBONERO L , de Ledinghen V, Moreno A, Maida I, et al
    Liver fibrosis in patients with chronic hepatitis C and persistently normal liver enzymes: influence of HIV infection.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
96. THEIN HH , Yi Q, Heathcote EJ, Krahn MD, et al
    Prognosis of hepatitis C virus-infected Canadian post-transfusion compensation claimant cohort.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
97. ELEFSINIOTIS IS , Pavlidis C, Dimitroulopoulos D, Vezali E, et al
    Differential viral kinetics in treated genotype 4 chronic hepatitis C patients according to ethnicity.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
98. CHEN ST , Ni YH, Chen PJ, Chen HL, et al
    Low viraemia at enrollment in children with chronic hepatitis C favours spontaneous viral clearance.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
99. LEHMAN EM , Wilson ML
    Epidemic hepatitis C virus infection in Egypt: estimates of past incidence and future morbidity and mortality.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
100. ALATRAKCHI N , Koziel M
     Regulatory T cells and viral liver disease.
     J Viral Hepat. 2009;16:223-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
101. REMPEL JD , Aborsangaya KB, Alphonse MP, Minuk GY, et al
     The influence of North American Aboriginal ethnicity on pro-inflammatory and anti-inflammatory cytokine responses to IFN-alpha.
     J Viral Hepat. 2009;16:292-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     March 2009
102. HANSEN N , Obel N, Christensen PB, Krarup H, et al
     Predictors of antiviral treatment initiation in hepatitis C virus-infected patients: a Danish cohort study.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
103. DERBALA M , Rizk N, Al-Kaabi S, Amer A, et al
     Adiponectin changes in HCV-Genotype 4: relation to liver histology and response to treatment.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
104. REDDY KR , Messinger D, Popescu M, Hadziyannis SJ, et al
     Peginterferon alfa-2a (40kDa) and ribavirin: comparable rates of sustained virological response in sub-sets of older and younger HCV genotype 1 patients.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
105. MELLO IM , Thumann C, Schvoerer E, Soulier E, et al
     Conservation of hepatitis C virus nonstructural protein 3 amino acid sequence in viral isolates during liver transplantation.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
106. RUSSELL RS , Kawaguchi K, Meunier JC, Takikawa S, et al
     Mutational analysis of the hepatitis C virus E1 glycoprotein in retroviral pseudoparticles and cell-culture-derived H77/JFH1 chimeric infectious virus particles.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
107. MARTIN-BLONDEL G , Gales A, Bernad J, Cuzin L, et al
     Low interleukin-10 production by monocytes of patients with a self-limiting hepatitis C virus infection.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
108. LI C , Lu L, Zhang X, Murphy D, et al
     Entire genome sequences of two new HCV subtypes, 6r and 6s, and characterization of unique HVR1 variation patterns within genotype 6.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
109. PENE V , Hernandez C, Vauloup-Fellous C, Garaud-Aunis J, et al
     Sequential processing of hepatitis C virus core protein by host cell signal peptidase and signal peptide peptidase: a reassessment.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
110. WILLIAMS MJ , Lawson A, Neal KR, Ryder SD, et al
     Autoantibodies in chronic hepatitis C virus infection and their association with disease profile.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
111. TOMA S , Yamashiro T, Arakaki S, Shiroma J, et al
     Inhibition of intracellular hepatitis C virus replication by nelfinavir and synergistic effect with interferon-alpha.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
112. IWASA M , Hara N, Miyachi H, Tanaka H, et al
     Patients achieving clearance of HCV with interferon therapy recover from decreased retinol-binding protein 4 levels.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
113. CRAINE N , Parry J, O'Toole J, D'Arcy S, et al
     Improving blood-borne viral diagnosis; clinical audit of the uptake of dried blood spot testing offered by a substance misuse service.
     J Viral Hepat. 2009;16:219-22.
     PubMed     Text format     Related articles    Abstract available
     
     
     February 2009
114. VERA-OTAROLA J , Barria MI, Leon U, Marsac D, et al
     Hepatitis C virus quasispecies in plasma and peripheral blood mononuclear cells of treatment naive chronically infected patients.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
115. LIBRI NA , Barker SJ, Rosenberg WM, Semper AE, et al
     A class C CpG toll-like receptor 9 agonist successfully induces robust interferon-alpha production by plasmacytoid dendritic cells from patients chronically infected with hepatitis C.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
116. JOHN-BAPTISTE A , Varenbut M, Lingley M, Nedd-Roderique T, et al
     Treatment of hepatitis C infection for current or former substance abusers in a community setting.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
117. VAN DEN BERG CH , van de Laar TJ, Kok A, Zuure FR, et al
     Never injected, but hepatitis C virus-infected: a study among self-declared never-injecting drug users from the Amsterdam Cohort Studies.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
118. KIM SJ , Kim JH, Sun JM, Kim MG, et al
     Suppression of hepatitis C virus replication by protein kinase C-related kinase 2 inhibitors that block phosphorylation of viral RNA polymerase.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
119. CANNON NA , Donlin MJ, Mayes LM, Lyra AC, et al
     Evidence for action of ribavirin through the hepatitis C virus RNA polymerase.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
120. PRASAD L , Spicher VM, Negro F, Rickenbach M, et al
     Little evidence that hepatitis C virus leads to a higher risk of mortality in the absence of cirrhosis and excess alcohol intake: the Swiss Hepatitis C Cohort Study.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
121. CHANG ML , Sung KF, Sheen IS, Lin SM, et al
     A liver slice culture-based ex vivo assay to predict the outcome of antiviral therapy for chronic hepatitis C.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
122. GISMONDI MI , Becker PD, Diaz Carrasco JM, Guzman CA, et al
     Evolution of hepatitis C virus hypervariable region 1 in immunocompetent children born to HCV-infected mothers.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
123. GREBELY J , Raffa JD, Lai C, Krajden M, et al
     Low uptake of treatment for hepatitis C virus infection in a large community-based study of inner city residents.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
124. CHEUNG KJ , Tilleman K, Deforce D, Colle I, et al
     The HCV serum proteome: a search for fibrosis protein markers.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
125. VAN DEN BERG CH , Ruys TA, Nanlohy NM, Geerlings SE, et al
     Comprehensive longitudinal analysis of hepatitis C virus (HCV)-specific T cell responses during acute HCV infection in the presence of existing HIV-1 infection.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
126. NOMURA H , Miyagi Y, Tanimoto H, Ishibashi H, et al
     Impact of early viral kinetics on pegylated interferon alpha 2b plus ribavirin therapy in Japanese patients with genotype 2 chronic hepatitis C.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
127. ROTMAN Y , Katz L, Cohen M, Cohen-Ezra O, et al
     Low weight predicts neutropenia and peginterferon alfa-2a dose reductions during treatment for chronic hepatitis C.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
128. MORENO S , Garcia-Samaniego J, Moreno A, Ortega E, et al
     Noninvasive diagnosis of liver fibrosis in patients with HIV infection and HCV/HBV co-infection.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
129. PHAM TN , Mercer SE, Michalak TI
     Chronic hepatitis C and persistent occult hepatitis C virus infection are characterized by distinct immune cell cytokine expression profiles.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
130. MILAZZO L , Meroni L, Galazzi M, Cesari M, et al
     Does fluvastatin favour HCV replication in vivo? A pilot study on HIV-HCV coinfected patients.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
131. MAVROGIANNAKI A , Karamanos B, Manesis EK, Papatheodoridis GV, et al
     Prevalence of glucose intolerance in patients with chronic hepatitis B or C: a prospective case-control study.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
132. WADA M , Marusawa H, Yamada R, Nasu A, et al
     Association of genetic polymorphisms with interferon-induced haematologic adverse effects in chronic hepatitis C patients.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
133. TARANTINO G , Marco VD, Petta S, Almasio PL, et al
     Serum BLyS/BAFF predicts the outcome of acute hepatitis C virus infection.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
134. CROSS TJ , Quaglia A, Hughes S, Joshi D, et al
     The impact of hepatic steatosis on the natural history of chronic hepatitis C infection.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
135. SANVISENS A , Serra I, Tural C, Tor J, et al
     Hyaluronic acid, transforming growth factor-beta1 and hepatic fibrosis in patients with chronic hepatitis C virus and human immunodeficiency virus co-infection.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     December 2008
136. CASTANEDA-SCEPPA C , Bermudez OI, Wanke C, Forrester JE, et al
     Predictors of insulin resistance among Hispanic adults infected with or at risk of infection with the human immunodeficiency virus and hepatitis C virus.
     J Viral Hepat. 2008;15:878-87.
     PubMed     Text format     Related articles    Abstract available
     
     
     
137. REGEARD M , Trotard M, Lepere C, Gripon P, et al
     Entry of pseudotyped hepatitis C virus into primary human hepatocytes depends on the scavenger class B type I receptor.
     J Viral Hepat. 2008;15:865-70.
     PubMed     Text format     Related articles    Abstract available
     
     
     
138. FARQUHAR MJ , McKeating JA
     Primary hepatocytes as targets for Hepatitis C virus replication.
     J Viral Hepat. 2008;15:849-54.
     PubMed     Text format     Related articles    Abstract available
     
     
     November 2008
139. SUTTON AJ , Hope VD, Mathei C, Mravcik V, et al
     A comparison between the force of infection estimates for blood-borne viruses in injecting drug user populations across the European Union: a modelling study.
     J Viral Hepat. 2008;15:809-16.
     PubMed     Text format     Related articles    Abstract available
     
     
     October 2008
140. ALVAREZ-LAJONCHERE L , Shoukry NH, Gra B, Amador-Canizares Y, et al
     Immunogenicity of CIGB-230, a therapeutic DNA vaccine preparation, in HCV-chronically infected individuals in a Phase I clinical trial.
     J Viral Hepat. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
141. PATEL K , Benhamou Y, Yoshida EM, Kaita KD, et al
     An independent and prospective comparison of two commercial fibrosis marker panels (HCV FibroSURE and FIBROSpect II) during albinterferon alfa-2b combination therapy for chronic hepatitis C.
     J Viral Hepat. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
142. ROSS RS , Viazov S, Clauberg R, Wolters B, et al
     Lack of de novo hepatitis C virus infections and absence of nosocomial transmissions of GB virus C in a large cohort of German haemodialysis patients.
     J Viral Hepat. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
143. GONZALEZ SA , Fiel MI, Sauk J, Canchis PW, et al
     Inverse association between hepatic stellate cell apoptosis and fibrosis in chronic hepatitis C virus infection.
     J Viral Hepat. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
144. FOUCHER J , Reiller B, Jullien V, Leal F, et al
     FibroScan used in street-based outreach for drug users is useful for hepatitis C virus screening and management: a prospective study.
     J Viral Hepat. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
145. VERGNIOL J , Foucher J, Castera L, Bernard PH, et al
     Changes of non-invasive markers and FibroScan values during HCV treatment.
     J Viral Hepat. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
146. FRIEDRICH-RUST M , Theobald J, Zeuzem S, Bojunga J, et al
     Thyroid function and changes in ultrasound morphology during antiviral therapy with pegylated interferon and ribavirin in patients with chronic hepatitis C.
     J Viral Hepat. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
147. MESHKAT Z , Audsley M, Beyer C, Gowans EJ, et al
     Reverse genetic analysis of a putative, influenza virus M2 HXXXW-like motif in the p7 protein of hepatitis C virus.
     J Viral Hepat. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     August 2008
148. ZEUZEM S , Berg T, Moeller B, Hinrichsen H, et al
     Expert opinion on the treatment of patients with chronic hepatitis C.
     J Viral Hepat. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
149. DE FELIPE B , Leal M, Soriano-Sarabia N, Gutierrez A, et al
     HCV RNA in peripheral blood cell subsets in HCV-HIV coinfected patients at the end of PegIFN/RBV treatment is associated with virologic relapse.
     J Viral Hepat. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
150. ANDRIULLI A , Cursaro C, Cozzolongo R, Iacobellis A, et al
     Early discontinuation of ribavirin in HCV-2 and HCV-3 patients responding to Peg-interferon alpha-2a and ribavirin.
     J Viral Hepat. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     July 2008
151. XIROUCHAKIS E , Triantos C, Manousou P, Sigalas A, et al
     Pegylated-interferon and ribavirin in liver transplant candidates and recipients with HCV cirrhosis: systematic review and meta-analysis of prospective controlled studies.
     J Viral Hepat. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
152. HOFMANN WP , Kronenberger B, Bojunga J, Stamm B, et al
     Prospective study of bone mineral density and metabolism in patients with chronic hepatitis C during pegylated interferon alpha and ribavirin therapy.
     J Viral Hepat. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
153. ZEREMSKI M , Shu MA, Brown Q, Wu Y, et al
     Hepatitis C virus-specific T-cell immune responses in seronegative injection drug users.
     J Viral Hepat. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
154. BRANT LJ , Hurrelle M, Balogun MA, Klapper P, et al
     Where are people being tested for anti-HCV in England? Results from sentinel laboratory surveillance.
     J Viral Hepat. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
155. TOYODA H , Kumada T, Kiriyama S, Sone Y, et al
     Correlation of serum ribavirin concentration with pretreatment renal function estimates in patients with chronic hepatitis C receiving combination antiviral therapy with peginterferon and ribavirin.
     J Viral Hepat. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
156. SCHERZER TM , Reddy KR, Wrba F, Hofer H, et al
     Hepatocellular carcinoma in long-term sustained virological responders following antiviral combination therapy for chronic hepatitis C.
     J Viral Hepat. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
157. SUTTON AJ , Edmunds WJ, Sweeting MJ, Gill ON, et al
     The cost-effectiveness of screening and treatment for hepatitis C in prisons in England and Wales: a cost-utility analysis.
     J Viral Hepat. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
158. BRANT LJ , Ramsay ME, Balogun MA, Boxall E, et al
     Diagnosis of acute hepatitis C virus infection and estimated incidence in low- and high-risk English populations.
     J Viral Hepat. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
159. BRUGGMANN P , Falcato L, Dober S, Helbling B, et al
     Active intravenous drug use during chronic hepatitis C therapy does not reduce sustained virological response rates in adherent patients.
     J Viral Hepat. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
160. WANG SH , Huang CX, Ye L, Wang X, et al
     Natural killer cells suppress full cycle HCV infection of human hepatocytes.
     J Viral Hepat. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
161. MARTIN-CARBONERO L , Puoti M, Garcia-Samaniego J, De Luca A, et al
     Response to pegylated interferon plus ribavirin in HIV-infected patients with chronic hepatitis C due to genotype 4.
     J Viral Hepat. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
162. GAMBARIN-GELWAN M , Jacobson IM
     Optimal dose of peginterferon and ribavirin for treatment of chronic hepatitis C.
     J Viral Hepat. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
163. ECHEVERRIA I , Zabaleta A, Silva L, Diaz-Valdes N, et al
     Monocyte-derived dendritic cells from HCV-infected patients transduced with an adenovirus expressing NS3 are functional when stimulated with the TLR3 ligand poly(I:C).
     J Viral Hepat. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
164. LALAZAR G , Pappo O, Hershcovici T, Hadjaj T, et al
     A continuous (13)C methacetin breath test for noninvasive assessment of intrahepatic inflammation and fibrosis in patients with chronic HCV infection and normal ALT.
     J Viral Hepat. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     June 2008
165. POYNARD T , Munteanu M, Ngo Y, Moussalli J, et al
     FibroTest is effective in patients with normal transaminases, when accuracy is standardized on fibrosis stage prevalence.
     J Viral Hepat. 2008;15:472-3.
     PubMed     Text format     Related articles   
     
     
     May 2008
166. TARANTINO G , Basile V, Conca P, Ariello M, et al
     Could the depression of obese patients suffering from chronic hepatitis C be temporarily improved?
     J Viral Hepat. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
167. TSENG FC , Edlin BR, Zhang M, Kral A, et al
     The inverse relationship between chronic HBV and HCV infections among injection drug users is associated with decades of age and drug use.
     J Viral Hepat. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
168. WEILAND O , Hollander A, Mattsson L, Glaumann H, et al
     Lower-than-standard dose peg-IFN alfa-2a for chronic hepatitis C caused by genotype 2 and 3 is sufficient when given in combination with weight-based ribavirin.
     J Viral Hepat. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
169. CHOU R , Carson S, Chan BK
     Pegylated interferons for chronic hepatitis C virus infection: an indirect analysis of randomized trials.
     J Viral Hepat. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
170. DERBALA MF , El Dweik NZ, Al Kaabi SR, Al-Marri AD, et al
     Viral kinetic of HCV genotype-4 during pegylated interferon alpha 2a: ribavirin therapy.
     J Viral Hepat. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
171. SCHIAVON LL , Narciso-Schiavon JL, Carvalho Filho RJ, Sampaio JP, et al
     Serum levels of YKL-40 and hyaluronic acid as noninvasive markers of liver fibrosis in haemodialysis patients with chronic hepatitis C virus infection.
     J Viral Hepat. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
172. ZAMPINO R , Ingrosso D, Durante-Mangoni E, Capasso R, et al
     Microsomal triglyceride transfer protein (MTP) -493G/T gene polymorphism contributes to fat liver accumulation in HCV genotype 3 infected patients.
     J Viral Hepat. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
173. CUEVAS JM , Torres-Puente M, Jimenez-Hernandez N, Bracho MA, et al
     Refined analysis of genetic variability parameters in hepatitis C virus and the ability to predict antiviral treatment response.
     J Viral Hepat. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
174. SHUDO E , Ribeiro RM, Perelson AS
     Modelling hepatitis C virus kinetics during treatment with pegylated interferon alpha-2b: errors in the estimation of viral kinetic parameters.
     J Viral Hepat. 2008;15:357-62.
     PubMed     Text format     Related articles    Abstract available
     
     
     April 2008
175. FABRIZI F , Ganeshan SV, Lunghi G, Messa P, et al
     Antiviral therapy of hepatitis C in chronic kidney diseases: meta-analysis of controlled clinical trials.
     J Viral Hepat. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
176. THOMSON EC , Main J
     Epidemiology of hepatitis C virus infection in HIV-infected individuals.
     J Viral Hepat. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
177. NGUYEN TH , Jacobs P, Hanrahan A, Fraser-Lee N, et al
     Health care costs of persons with newly diagnosed hepatitis C virus: a population-based, observational study.
     J Viral Hepat. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
178. STRAUSS R , Torner A, Duberg AS, Hultcrantz R, et al
     Hepatocellular carcinoma and other primary liver cancers in hepatitis C patients in Sweden - a low endemic country.
     J Viral Hepat. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
179. DUBERG AS , Torner A, Daviethsdottir L, Aleman S, et al
     Cause of death in individuals with chronic HBV and/or HCV infection, a nationwide community-based register study.
     J Viral Hepat. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
180. SEBASTIANI G , Vario A, Guido M, Alberti A, et al
     Performance of noninvasive markers for liver fibrosis is reduced in chronic hepatitis C with normal transaminases.
     J Viral Hepat. 2008;.
     PubMed     Text format     Related articles   
     
     
     
181. KANG SM , Choi SH, Park CY, Kim MH, et al
     Monoclonal antibody recognizing N-terminal epitope of hepatitis C virus nonstructural 5B inhibits viral RNA replication.
     J Viral Hepat. 2008;15:305-13.
     PubMed     Text format     Related articles    Abstract available
     
     
     
182. NAPOLI N , Giannelli G, Antonaci A, Antonaci S, et al
     The use of different Peg-interferon alpha-2b regimens plus ribavirin in HCV-1b-infected patients after rapid virological response does not affect the achievement of sustained virological response.
     J Viral Hepat. 2008;15:300-4.
     PubMed     Text format     Related articles    Abstract available
     
     
     
183. NAKAMURA J , Toyabe SI, Aoyagi Y, Akazawa K, et al
     Economic impact of extended treatment with peginterferon alpha-2a and ribavirin for slow hepatitis C virologic responders.
     J Viral Hepat. 2008;15:293-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
184. YE L , Peng JS, Wang X, Wang YJ, et al
     Methamphetamine enhances Hepatitis C virus replication in human hepatocytes.
     J Viral Hepat. 2008;15:261-70.
     PubMed     Text format     Related articles    Abstract available
     
     
     
185. BANI-SADR F , Lapidus N, Melchior JC, Ravaux I, et al
     Severe weight loss in HIV / HCV-coinfected patients treated with interferon plus ribavirin: incidence and risk factors.
     J Viral Hepat. 2008;15:255-60.
     PubMed     Text format     Related articles    Abstract available
     
     
     March 2008
186. MCHUTCHISON J , Sulkowski M
     Scientific rationale and study design of the individualized dosing efficacy vs flat dosing to assess optimal pegylated interferon therapy (IDEAL) trial: determining optimal dosing in patients with genotype 1 chronic hepatitis C.
     J Viral Hepat. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
187. WARD CL , Dev A, Rigby S, Symonds WT, et al
     Interferon and ribavirin therapy does not select for resistance mutations in hepatitis C virus polymerase.
     J Viral Hepat. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
188. BORTOLAMI M , Kotsafti A, Cardin R, Farinati F, et al
     Fas / FasL system, IL-1beta expression and apoptosis in chronic HBV and HCV liver disease.
     J Viral Hepat. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
189. AGHEMO A , Rumi MG, Colombo M
     Is a 24 week treatment schedule with PegInterferon and Ribavirin too short for HCV genotype 3 cirrhotics?
     J Viral Hepat. 2008;.
     PubMed     Text format     Related articles   
     
     
     
190. FUJITA N , Sugimoto R, Ma N, Tanaka H, et al
     Comparison of hepatic oxidative DNA damage in patients with chronic hepatitis B and C.
     J Viral Hepat. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
191. CIESEK S , Liermann H, Hadem J, Greten T, et al
     Impaired TRAIL-dependent cytotoxicity of CD1c-positive dendritic cells in chronic hepatitis C virus infection.
     J Viral Hepat. 2008;15:200-11.
     PubMed     Text format     Related articles    Abstract available
     
     
     
192. TORRES-PUENTE M , Cuevas JM, Jimenez-Hernandez N, Bracho MA, et al
     Genetic variability in hepatitis C virus and its role in antiviral treatment response.
     J Viral Hepat. 2008;15:188-99.
     PubMed     Text format     Related articles    Abstract available
     
     
     
193. BRUCE MG , Bruden D, McMahon BJ, Christensen C, et al
     Clinical significance of elevated alpha-fetoprotein in Alaskan Native patients with chronic hepatitis C.
     J Viral Hepat. 2008;15:179-87.
     PubMed     Text format     Related articles    Abstract available
     
     
     February 2008
194. SHUDO E , Ribeiro RM, Perelson AS
     Modelling the kinetics of hepatitis C virus RNA decline over 4 weeks of treatment with pegylated interferon alpha-2b.
     J Viral Hepat. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
195. TARANTINO G , Cabibi D, Camma C, Alessi N, et al
     Liver eosinophilic infiltrate is a significant finding in patients with chronic hepatitis C.
     J Viral Hepat. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
196. GIGI E , Raptopoulou-Gigi M, Kalogeridis A, Masiou S, et al
     Cytokine mRNA expression in hepatitis C virus infection: TH1 predominance in patients with chronic hepatitis C and TH1-TH2 cytokine profile in subjects with self-limited disease.
     J Viral Hepat. 2008;15:145-54.
     PubMed     Text format     Related articles    Abstract available   Free Full Text
     
     
     
197. VILLACRES MC , Literat O, Degiacomo M, Du W, et al
     Defective response to Toll-like receptor 3 and 4 ligands by activated monocytes in chronic hepatitis C virus infection.
     J Viral Hepat. 2008;15:137-44.
     PubMed     Text format     Related articles    Abstract available   Free Full Text
     
     
     
198. REDDY KR , Govindarajan S, Marcellin P, Bernstein D, et al
     Hepatic steatosis in chronic hepatitis C: baseline host and viral characteristics and influence on response to therapy with peginterferon alpha-2a plus ribavirin.
     J Viral Hepat. 2008;15:129-36.
     PubMed     Text format     Related articles    Abstract available   Free Full Text
     
     
     
199. MOSLEY JW , Operskalski EA, Tobler LH, Buskell ZJ, et al
     The course of hepatitis C viraemia in transfusion recipients prior to availability of antiviral therapy.
     J Viral Hepat. 2008;15:120-8.
     PubMed     Text format     Related articles    Abstract available   Free Full Text
     
     
     
200. FRESHWATER DA , O'Donnell K, Mutimer DJ
     Inferior response of Asian vs non-Asian hepatitis C genotype 3 infection to combination antiviral therapy.
     J Viral Hepat. 2008;15:115-9.
     PubMed     Text format     Related articles    Abstract available   Free Full Text
     
     
     
201. FABRIZI F , Dixit V, Messa P, Martin P, et al
     Interferon monotherapy of chronic hepatitis C in dialysis patients: meta-analysis of clinical trials.
     J Viral Hepat. 2008;15:79-88.
     PubMed     Text format     Related articles    Abstract available   Free Full Text
     
     
     
202. BOUSTIERE CH , Napoleon B, Delasalle P, Coulom P, et al
     Digestive endoscopies are not a risk factor for transmission of virus C.
     J Viral Hepat. 2008;15:155.
     PubMed     Text format     Related articles   
     
     
     January 2008
203. MATHEI C , Van Dooren S, Lemey P, Van Damme P, et al
     The epidemic history of hepatitis C among injecting drug users in Flanders, Belgium.
     J Viral Hepat. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
204. YU H , Babiuk LA, van Drunen Littel-van den Hurk S
     Strategies for loading dendritic cells with hepatitis C NS5a antigen and inducing protective immunity.
     J Viral Hepat. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
205. SHEA DO , Tuite H, Farrell G, Codd M, et al
     Role of rapid virological response in prediction of sustained virological response to Peg-IFN plus ribavirin in HCV / HIV co-infected individuals.
     J Viral Hepat. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
206. HAMED MR , Tarr AW, McClure CP, Ball JK, et al
     Association of antibodies to hepatitis C virus glycoproteins 1 and 2 (anti-E1E2) with HCV disease.
     J Viral Hepat. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
207. DE LEDINGHEN V , Barreiro P, Foucher J, Labarga P, et al
     Liver fibrosis on account of chronic hepatitis C is more severe in HIV-positive than HIV-negative patients despite antiretroviral therapy.
     J Viral Hepat. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
208. RUYS TA , Nanlohy NM, van den Berg CH, Hassink E, et al
     HCV-specific T-cell responses in injecting drug users: evidence for previous exposure to HCV and a role for CD4+ T cells focussing on nonstructural proteins in viral clearance.
     J Viral Hepat. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
209. DE P , Roy E, Boivin JF, Cox J, et al
     Risk of hepatitis C virus transmission through drug preparation equipment: a systematic and methodological review.
     J Viral Hepat. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
210. BLACKARD JT , Sherman KE
     HCV/ HIV co-infection: time to re-evaluate the role of HIV in the liver?
     J Viral Hepat. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
211. MANN AG , Trotter CL, Adekoyejo Balogun M, Ramsay ME, et al
     Hepatitis C in ethnic minority populations in England.
     J Viral Hepat. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
212. BARNES E , Salio M, Cerundolo V, Francesco L, et al
     Monocyte derived dendritic cells retain their functional capacity in patients following infection with hepatitis C virus.
     J Viral Hepat. 2008;.
     PubMed     Text format     Related articles    Abstract available   Free Full Text
     
     
     
213. YOUNOSSI ZM , Nader FH, Bai C, Sjogren R, et al
     A phase II dose finding study of darbepoetin alpha and filgrastim for the management of anaemia and neutropenia in chronic hepatitis C treatment.
     J Viral Hepat. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     December 2007
214. SEBASTIANI G , Vario A, Guido M, Alberti A, et al
     Performance of noninvasive markers for liver fibrosis is reduced in chronic hepatitis C with normal transaminases.
     J Viral Hepat. 2007;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
215. NUNEZ M , Ocampo A, Aguirrebengoa K, Cervantes M, et al
     Incidence of anaemia and impact on sustained virological response in HIV/HCV-coinfected patients treated with pegylated interferon plus ribavirin.
     J Viral Hepat. 2007;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
216. PEREZ-BERNA AJ , Veiga AS, Castanho MA, Villalain J, et al
     Hepatitis C virus core protein binding to lipid membranes: the role of domains 1 and 2.
     J Viral Hepat. 2007;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
217. GONZALEZ SA , Zhang C, Fiel MI, Chung S, et al
     Hepatic inflammatory cytokine mRNA expression in hepatitis C virus-human immunodeficiency virus co-infection.
     J Viral Hepat. 2007;.
     PubMed     Text format     Related articles    Abstract available
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: